Centro de Investigaciones Medicas Tucuman

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)	Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis	Recruiting	Phase 2	2026-09-21		NCT07137598
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome	Primary Sjogrens Disease	Active, not recruiting	Phase 3	2026-04-16		NCT06684847

Clinical trials